Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 26 (RPL36AP26) is a human processed pseudogene derived from the ribosomal protein L36a gene family. It is mapped to the human genome and retains sequence similarity to the parent ribosomal protein gene but does not encode a functional protein product. Like other processed pseudogenes of ribosomal proteins, it has no known translational, regulatory, or disease-related function and is not considered a therapeutic target[5][6][7][8]. The functional counterpart is ribosomal protein L36a (RPL36A), which is part of the ribosomal large (60S) subunit and plays a role in protein synthesis in the cell[1][2][3]. There are numerous processed pseudogenes derived from RPL36A scattered throughout the genome[1][3], but these, including RPL36AP26, are non-coding[5][7]. The gene symbol and synonyms such as "RPL36A_8_787" are alternate database designations for this pseudogene[6]. If you are seeking a protein-coding or therapeutically relevant ribosomal subunit, the correct target would be "Ribosomal protein L36a" (RPL36A), not RPL36AP26[1][2][3].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 26 (RPL36AP26).